ATE425758T1 - Modifizierte polysaccharide mit veranderter biologischer erkennung - Google Patents

Modifizierte polysaccharide mit veranderter biologischer erkennung

Info

Publication number
ATE425758T1
ATE425758T1 AT98962025T AT98962025T ATE425758T1 AT E425758 T1 ATE425758 T1 AT E425758T1 AT 98962025 T AT98962025 T AT 98962025T AT 98962025 T AT98962025 T AT 98962025T AT E425758 T1 ATE425758 T1 AT E425758T1
Authority
AT
Austria
Prior art keywords
altered biological
biological detection
modified polysaccharides
polysaccharides
altered
Prior art date
Application number
AT98962025T
Other languages
English (en)
Inventor
Bo Hedlund
Thomas Weber
Paul Dragsten
Gregory Hanson
Philip Hallaway
Original Assignee
Biomed Frontiers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomed Frontiers Inc filed Critical Biomed Frontiers Inc
Application granted granted Critical
Publication of ATE425758T1 publication Critical patent/ATE425758T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT98962025T 1997-12-09 1998-12-09 Modifizierte polysaccharide mit veranderter biologischer erkennung ATE425758T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6907997P 1997-12-09 1997-12-09
US6909597P 1997-12-11 1997-12-11

Publications (1)

Publication Number Publication Date
ATE425758T1 true ATE425758T1 (de) 2009-04-15

Family

ID=26749664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98962025T ATE425758T1 (de) 1997-12-09 1998-12-09 Modifizierte polysaccharide mit veranderter biologischer erkennung

Country Status (12)

Country Link
US (1) US6479468B1 (de)
EP (1) EP1037642B9 (de)
JP (1) JP4435412B2 (de)
AT (1) ATE425758T1 (de)
AU (1) AU761784B2 (de)
BR (1) BR9813465A (de)
CA (1) CA2314716C (de)
DE (1) DE69840673D1 (de)
DK (1) DK1037642T3 (de)
ES (1) ES2325005T3 (de)
TR (1) TR200001682T2 (de)
WO (1) WO1999029328A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236224A1 (en) * 1997-12-09 2003-12-25 Hedlund Bo E. Modified polysaccharides exhibiting altered biological recognition
US6780852B2 (en) 1997-12-09 2004-08-24 Bo E. Hedlund Modified polysaccharides exhibiting altered biological recognition
WO2002026240A2 (en) * 2000-09-26 2002-04-04 Sidney Kimmel Cancer Center Inhibition of antigen presentation with poorly catabolized polymers
EP1707632A1 (de) * 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylierte waxy-Kartoffelstärke
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US8974799B2 (en) 2009-09-30 2015-03-10 Novartis Ag Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
ES2846848T3 (es) * 2015-10-26 2021-07-29 Harvard College Polisacáridos reducidos y oxidados y métodos de uso de los mismos
ES3051396T3 (en) * 2017-06-13 2025-12-29 Merz Pharma Gmbh & Co Kgaa Mixing nozzle, application device, kit and method using the mixing nozzle or application device
CN110809402A (zh) * 2017-07-06 2020-02-18 拜耳股份公司 用于杂草控制的装置

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH406175A (de) * 1959-12-23 1966-01-31 Chugai Pharmaceutical Co Ltd Verfahren zur Herstellung eines Reduktionsproduktes von oxydierter Stärke
NL270107A (de) 1960-10-11 1964-07-10
JPS5634701A (en) * 1979-08-29 1981-04-07 Meito Sangyo Kk Beta-1,3-glucan, its preparation and use
US4419365A (en) 1981-12-21 1983-12-06 Ciba-Geigy Corporation Method of treating Alzheimer's disease
US4863964A (en) 1985-07-02 1989-09-05 Biomedical Frontiers, Inc. Method for the stabilization of deferoxamine to chelate free ions in physiological fluid
US5217998A (en) * 1985-07-02 1993-06-08 Biomedical Frontiers, Inc. Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
US4863961A (en) * 1985-11-25 1989-09-05 G. D. Searle & Co. Tetraenyl prostaglandins
US4987253A (en) 1988-09-19 1991-01-22 University Of Florida Method for the synthesis of desferrioxamine B and analogs thereof
US5268165A (en) 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
US5493053A (en) 1994-12-21 1996-02-20 University Of Florida Research Foundation, Inc. Method for preparing desferrioxamine B and homologs thereof
US5811510A (en) * 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
US5847110A (en) 1997-08-15 1998-12-08 Biomedical Frontiers, Inc. Method of reducing a schiff base

Also Published As

Publication number Publication date
AU1719799A (en) 1999-06-28
AU761784B2 (en) 2003-06-12
DK1037642T3 (da) 2009-07-06
ES2325005T3 (es) 2009-08-21
EP1037642B1 (de) 2009-03-18
CA2314716C (en) 2009-02-03
US6479468B1 (en) 2002-11-12
JP2001525369A (ja) 2001-12-11
TR200001682T2 (tr) 2001-02-21
DE69840673D1 (de) 2009-04-30
CA2314716A1 (en) 1999-06-17
JP4435412B2 (ja) 2010-03-17
EP1037642B9 (de) 2010-10-13
BR9813465A (pt) 2002-01-22
EP1037642A1 (de) 2000-09-27
WO1999029328A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
ES2110386T3 (es) Conjugados de interferon.
DE69830326D1 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
HN1996000017A (es) Isotiazolonas
CY1114197T1 (el) Μεθοδος διαμορφωσης της δραστικοτητας λειτουργικων ανοσομοριων
PT871619E (pt) Derivados de fenil-tiazol com propriedades anti-virus do herpesc
DE69914119D1 (de) Verbesserungen an, oder bezüglich, Rohrkupplungen
ATE196479T1 (de) Mit antioxidantien gepfropfte polysaccharide und deren verwendungen
DE60010098D1 (de) 28-epirapaloge
ID23374A (id) Halogenopirimidin
DE69914928D1 (de) Polymerkomplexe von glukuronoglukanen
DE50012863D1 (de) Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften
BR9711117A (pt) Oligossacarídios modificados.
FI980551A7 (fi) Transformoidut mikro-organismit, joilla on parannettuja ominaisuuksia
DE69902010D1 (de) Kardierbare doppelglasfasermischung
EE03619B1 (et) Süsivesik-modifitseeritud tsütostaatikumid
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
PT1216256E (pt) Antibioticos macrolidos e tratamento de pasteurelose
ATE425758T1 (de) Modifizierte polysaccharide mit veranderter biologischer erkennung
FR2753978B1 (fr) Composition thermodurcissable, ses utilisations et preforme souple depliable comprenant cette composition
FI965064L (fi) Veteenliukeneva suurimolekyylinen yhdiste, joka sisältää silikonia ja sen tuotanto ja käyttö
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
ATE298373T1 (de) Immunstimulierende phellinus ssp. polysaccharid und verwendung
EA200400393A1 (ru) Антитела против каспазы-8, их получение и применение
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties